Letrozole
Clarzole contains the active substance letrozole. It belongs to a group of medicines called aromatase inhibitors. It is used in the hormonal (endocrine) treatment of breast cancer. The growth of breast cancer is often stimulated by estrogens, which are female sex hormones. Clarzole reduces the amount of estrogen by inhibiting the activity of the enzyme (aromatase) involved in the production of estrogens, and thus can slow down the growth of malignant breast tumors that need estrogens to grow. As a result of this effect, cancer cells stop growing or grow slowly and (or) stop spreading to other parts of the body.
Clarzole is used to treat breast cancer in postmenopausal women, i.e., women who have stopped menstruating. This medicine is used to prevent the recurrence of breast cancer. It can be used as the first treatment before breast surgery, when immediate surgery is not recommended, or as the first treatment after breast surgery, or after five years of tamoxifen treatment. Clarzole is also used to prevent the spread of breast cancer to other parts of the body in patients with advanced breast cancer. If you have any questions about how Clarzole works or why it has been prescribed for you, ask your doctor.
Follow the instructions of your doctor. They may be different from the general information in this leaflet.
Do not takethis medicine if any of these points apply to you - consult your doctor.
Before starting treatment with Clarzole, discuss it with your doctor or pharmacist.
Letrozole may cause inflammation or damage to tendons (see section 4). If you experience pain or swelling of a tendon, rest the affected area and contact your doctor.
This medicine should not be used in children and adolescents.
Patients aged 65 and over can use this medicine at the same dose as other adult patients.
Tell your doctor or pharmacist about all the medicines you are taking now or have taken recently, as well as any medicines you plan to take.
If you experience dizziness, fatigue, drowsiness, or general malaise, do not drive or operate machinery until your condition improves.
Clarzole contains lactose (milk sugar). If you have been diagnosed with intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol (23 mg) of sodium per film-coated tablet, which is considered to be "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist. The usual dose is one film-coated tablet of Clarzole taken once a day. Taking Clarzole at the same time every day will help you remember to take your tablet. You can take the tablet with or without food, and you should swallow it whole with a glass of water or another liquid.
Take Clarzole every day for as long as your doctor has prescribed it. You may need to take it for several months or even years. If you have any questions about how long to take Clarzole, ask your doctor.
This medicine should always be taken under close medical supervision. Your doctor will regularly check your health to ensure that the treatment is working properly. Clarzole may cause thinning or loss of bone tissue (osteoporosis) related to the decrease in estrogen levels in the body. Your doctor may order a bone density test before, during, and after treatment to check for osteoporosis.
If you have taken more than the prescribed dose of Clarzole or if someone has accidentally taken your tablets, contact your doctor or go to the hospital immediately. Show them the medicine pack. You may need treatment.
Do not stop taking Clarzole unless your doctor tells you to (see "How long to take Clarzole" in section 3). If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Clarzole can cause side effects, although not everybody gets them. Most of the observed side effects are mild to moderate and usually appear within a few days to a few weeks of treatment. Some of them, such as hot flashes, hair loss, or vaginal bleeding, may be a consequence of the lack of estrogen in the body. Do not be concerned about all the possible side effects listed below. They may not occur at all.
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
You should also tell your doctor immediately if you experience any of the following symptoms during treatment with Clarzole:
Other side effects
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Unknown(frequency cannot be estimated from the available data)
If any of these symptoms occur in a severe form, tell your doctor.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. This medicine does not require any special storage conditions. Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Clarzole, 2.5 mg, film-coated tablets are yellow, round, and biconvex. The medicine is available in packs of:
Blisters: 30, 60 film-coated tablets. Not all pack sizes may be marketed.
Actavis Group PTC ehf.
220 Hafnarfjörður
Iceland
S.C. Sindan – Pharma S.R.L.
11 Ion Mihalache Blvd
011171 Bucharest
Romania
Teva Pharmaceuticals Polska Sp. z o.o., ul. Emilii Plater 53, 00-113 Warsaw, tel. (22) 345 93 00.
Date of last revision of the leaflet:May 2023.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.